Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPRENT Trial
PACTR202503893791588Phase 1Completed
- Sponsor
- Tanta University Hospitals
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of silodosin in nephrolithiasis (2 arms), sponsored by Tanta University Hospitals. Primary endpoint: Stone expulsion time for small stone fragments. Started Jan 2019; status: completed.
02
Drugs
silodosin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on PACTR202503893791588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503893791588.